NEXT Life Sciences announced that world-renowned vasectomy doctors have joined its medical advisory board, marking significant progress toward making a long-lasting, non-hormonal, reversible contraceptive available
The promise of new male contraceptive options was highlighted in an article by Kelcie Moseley-Morris published in News from the States. Heather Vahdat of the
The Parsemus Foundation founder and trustee, Elaine Lissner, was invited to speak about male contraception at the SXSW event on March 10, 2023. SXSW (“south
NEXT Life Sciences, Inc. announced on March 22, 2023 its plans for the Plan A™ male contraceptive. Vasalgel, the polymer hydrogel developed by the Parsemus
The Male Contraceptive Initiative Youth Advisory Board is offering a grant to undergraduate students for research on male contraception. Undergraduate students anywhere in the world
The Parsemus Foundation and Revolution Contraceptives LLC are pleased to announce that NEXT Life Sciences, Inc. has been selected to continue development of the Vasalgel
The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud
The Male Contraceptive Initiative announced that the Youth Advisory Board Undergraduate Project Grant program is accepting applications until September 30, 2021. The grant aims to
Years of grassroots efforts to support women’s reproductive rights was recently successful in legalizing abortion in Argentina. Argentina’s president, Alberto Fernández, was a supporter and
Elaine Lissner, founder of the Parsemus Foundation, recently participated in an ideation workshop in San Francisco for the Male Contraceptive Initiative (MCI). The goal of
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:
